Tag Archives | GILD

ASCO Day 2 Briefs and Daily Movers: ARRY,GILD,IBB,IMGN,SGEN

Apparently ASCO Is “Sell On the News” Trigger Another lackluster trading day with profit taking; the IBB  is down 2.3% and trading near its May bottom with a pronounced topping pattern.Moreover many funds and indices now own biotech stocks so without the general market rallying ((NASDAQ off 22 pts at 2:30 p EDT), the sector will […]

Continue Reading 0

Gilead Holding Up at $33 on Exhaustion of Negativity

Gilead (GILD) has finally caught some bids today up 0.5% on a volume of 23M (Ave. volume 12M) shares! Among the supporters of the stock are Leerink Swann who maintain their “Market Outperform” and price target of low 40’s and JPMorgan who reiterate their “Overweight”and reduced target of  $5 from $55. JPMorgan says the Street […]

Continue Reading 0

Gilead(GILD) and Abbott(ABT) Guidance Triggers Biotech Sell-Off

Healthcare Reform Impact on Gilead HIV Product Sales Surprises Analysts Gilead Sciences (GILD) lowered its 2010 sales forecast to a range of $7.4-$7.5B from $7.6-$7.8B citing recently enacted healthcare legislation. Net income for the quarter ended March 31 jumped from $854.9M or $0.92/sh. compared with $589.1M or $0.63/sh. in the Year ago period. Gilead’s first-quarter […]

Continue Reading 0